Action Agentix (PK) - AGTX

Agentix Corporation (PK) (AGTX) Action

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Dernier

0,017

( - )

Prix Achat

0,0122

Prix Vente

0,04

Volume échangé

0,00 Fourchette du Jour 0,00

0,0164 Plage de 52 semaines 0,055

Cap du marché

681,138k

Clôture Veille

0,017

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume financier

VWAP

Volume moyen (3 m)

US$ 13 745

Actions en circulation

40 066 951

Rendement du Dividende (LTM)

Ratio Cours sur Bénéfices

-1,43

Bénéfice par action (BPA)

-0,01

Chiffre d'affairess (LTM)

Bénéfice net (LTM)

-590,29k

Agentix Corp., a clinical development stage company, focuses on the development and commercialization of novel therapeutics to treat metabolic diseases in the United States. It develops AGTX-2004, a peripherally-acting CB1 receptor antagonist that has demonstrated efficacy in animal models of obesit... Agentix Corp., a clinical development stage company, focuses on the development and commercialization of novel therapeutics to treat metabolic diseases in the United States. It develops AGTX-2004, a peripherally-acting CB1 receptor antagonist that has demonstrated efficacy in animal models of obesity and type 2 diabetes mellitus; and AGTX-2003, a peripherally-acting CB1 receptor inverse agonist, which has demonstrated efficacy in animal models of obesity and non-alcoholic fatty liver diseases. The company was formerly known as FairWind Energy, Inc. and changed its name to Agentix Corp. in June 2019. Agentix Corp. was founded in 2020 and is based in Dana Point, California. Show more

Secteur

Healthcare

Industrie

Biotechnology & Life Sciences

Site Web

www.agentixcorp.com

Siège social

Dana Point, United States

Fondé

2026

Agentix Corporation (PK) est coté dans le secteur Healthcare de la OTC Markets avec le ticker AGTX. Le dernier cours de clôture d'Agentix (PK) était de US$0,02. Au cours de la dernière année, les actions de Agentix (PK) ont été négociées dans une fourchette de prix de US$ 0,0164 à US$ 0,055.

Agentix (PK) compte actuellement 40 066 951 actions en circulation. La capitalisation boursière d'Agentix (PK) est de US$681 138,17 . Agentix (PK) a un ratio cours/bénéfice (ratio PE) de -1.43.

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	-0.0047	-21.6589861751	0.0217	0.0217	0.0164	152565	0.017	CS
4	-0.008	-32	0.025	0.025	0.0164	77158	0.01705508	CS
12	-0.02395	-58.485958486	0.04095	0.0439	0.0164	29587	0.02283486	CS
26	-0.026	-60.4651162791	0.043	0.05	0.0164	19174	0.031754	CS
52	-0.0226	-57.0707070707	0.0396	0.055	0.0164	18949	0.03421572	CS
156	-0.043	-71.6666666667	0.06	0.46	0.0164	20271	0.05181192	CS
260	-1.073	-98.4403669725	1.09	1.48	0.0164	14074	0.07018035	CS

AGTX - Frequently Asked Questions (FAQ)

What is the current Agentix Corporation (PK) share price?

The current share price of Agentix Corporation (PK) is US$ 0,017

How many Agentix Corporation (PK) shares are in issue?

Agentix Corporation (PK) has 40 066 951 shares in issue

What is the market cap of Agentix Corporation (PK)?

The market capitalisation of Agentix Corporation (PK) is USD 681,14k

What is the 1 year trading range for Agentix Corporation (PK) share price?

Agentix Corporation (PK) has traded in the range of US$ 0,0164 to US$ 0,055 during the past year

What is the PE ratio of Agentix Corporation (PK)?

The price to earnings ratio of Agentix Corporation (PK) is -1,43

What is the registered address of Agentix Corporation (PK)?

The registered address for Agentix Corporation (PK) is 32932 Pacific Coast Highway, Dana Point, California, 92629

What is the Agentix Corporation (PK) website address?

The website address for Agentix Corporation (PK) is www.agentixcorp.com

Which industry sector does Agentix Corporation (PK) operate in?

Agentix Corporation (PK) operates in the Biotechnology & Life Sciences sector

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Agentix Corporation (PK) (AGTX)

Agentix Corporation (PK) (AGTX) Action

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

À propos de Agentix Corporation (PK)

AGTX Dernières nouvelles

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

AGTX - Frequently Asked Questions (FAQ)

AGTX Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Agentix Corporation (PK) (AGTX)

Agentix Corporation (PK) (AGTX) Action

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

À propos de Agentix Corporation (PK)

AGTX Dernières nouvelles

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

AGTX - Frequently Asked Questions (FAQ)

AGTX Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Pourquoi rejoindre ADVFN?

Tout ce dont les traders professionnels ont besoin.

Supprimer les publicités